a-Neo-Endorphin (1-7)

a-Neo-Endorphin (1-7) is a short opioid peptide fragment characterized by balanced hydrophobic and charged residues. The sequence supports mapping of receptor-binding determinants and conformational transitions. Its properties allow exploration of aromatic stacking and structural dynamics. Applications include neuropeptide modeling and peptide-protein interaction research.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: E05034

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.F/Formula
C40H61N11O9
M.W/Mr.
840.0
Sequence
YGGFLRK
Length
7

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide Modification ServicescGMP Peptide ServiceCustom Conjugation ServicePeptide CDMOEpitope Mapping ServicesPeptide Synthesis ServicesPeptide Analysis ServicesPeptide Nucleic Acids Synthesis
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers